MAP Patient Access Limited

MAP is the Market Access specialist for innovative technologies. We help companies overcome the most challenging access issues, especially when they are due to rarity or complexity. Drawing on over a decades worth of experience, MAP works with ambitious biopharma companies wishing to launch in the UK and Europe. Our unique integrated approach helps you navigate the complexities of the market access, pricing and reimbursement landscape. With offices in England and Europe, our expertise spans over 20 markets and makes us the partner of choice for facilitating successful market access in Europe. Our services include: Consultancy we are a market-leading...

Market access,health economics,public affairs,biotechnology,pharmaceuticals,medical devices,commissioning,news updates,horizon scanning,clinical writing,market access consultancy,health technology assessments,global value dossiers,systematic literature reviews,pricing & reimbursement,early engagement,medicine launch strategy,european health technology assessment,policy & public affairs,health economics,and hta data analysis

Map patient access limited operates in the Pharmaceutical manufacturing industry.

Map patient access limited's revenue is 11m - 100m

Map patient access limited has 51 - 200 employees.